NK:IO
NK:IO is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Seed, 2 tracked investors.
About NK:IO
NK:IO is a startup founded in 2020 based in the United Kingdom. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
NK:IO develops a novel cellular immunotherapy platform using natural killer (NK) cells to treat solid tumor cancers, initially targeting ovarian cancer. Their technology enables the production of highly potent, off-the-shelf NK cell therapies derived from umbilical cord blood stem cells, overcoming traditional manufacturing challenges.
Explore NK:IO's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.